Edition:
United Kingdom

Cellect Biotechnology Ltd (APOP.OQ)

APOP.OQ on NASDAQ Stock Exchange Capital Market

0.52USD
17 Sep 2019
Change (% chg)

-- (--)
Prev Close
$0.52
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
45,647
52-wk High
$5.90
52-wk Low
$0.40

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 0.00 -0.029
Sep '18 0.00 -0.052
Jun '18 0.00 -0.046
Mar '18 0.00 -0.028
FY 2017 Dec '17 0.00 -0.028
Sep '17 0.00 -0.070
Jun '17 0.00 -0.042
Mar '17 0.00 -0.137
 
*Note: Units in Millions ofShekel
**Note: Units in Shekel

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.39 32.66
P/E High - Last 5 Yrs. -- 147.53 47.31
P/E Low - Last 5 Yrs. -- 47.83 23.88
Beta 2.07 1.08 0.89
Price to Sales (TTM) -- 49.44 7.91
Price to Book (MRQ) 12.06 10.14 5.38
Price to Tangible Book (MRQ) 12.39 13.75 6.71
Price to Cash Flow (TTM) -- 55.95 24.36
% Owned Institutions -- 3.66 1.45

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.38
Dividend 5 Year Growth Rate -- 0.78 4.54
Payout Ratio(TTM) -- 7.01 40.24

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 205.58 12.23
Sales (TTM) vs TTM 1 Yr. Ago -- 49.07 7.74
Sales - 5 Yr. Growth Rate -- 22.80 10.88
EPS (MRQ) vs Qtr. 1 Yr. Ago -8.79 76.36 42.97
EPS (TTM) vs TTM 1 Yr. Ago -60.47 -- --
EPS - 5 Yr. Growth Rate -- 11.92 10.31
Capital Spending - 5 Yr. Growth Rate 35.30 9.20 14.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.23 2.21
Current Ratio (MRQ) 8.17 3.59 3.03
LT Debt to Equity (MRQ) 0.00 18.57 10.20
Total Debt to Equity (MRQ) 0.00 31.19 14.55
Interest Coverage (TTM) -345.79 -44.62 29.80

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.09 52.24
Gross Margin - 5 Yr. Avg. -- 60.28 50.41
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.44 13.12
Operating Margin (TTM) -- -183.66 6.81
Operating Margin - 5 Yr. Avg. -- -126.87 8.92
Pre-Tax Margin (TTM) -- -174.35 5.99
Pre-Tax Margin - 5 Yr. Avg. -- -132.63 9.22
Net Profit Margin (TTM) -- -181.04 2.63
Net Profit Margin - 5 Yr. Avg. -- -137.00 5.58
Effective Tax Rate (TTM) -- 22.42 22.40
Effective Tax Rate - 5 Yr. Avg. -- 15.43 22.75

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,668,680 887,292,930
Net Income/Employee (TTM) -- 533,005 101,845,229
Receivable Turnover (TTM) -- 6.23 5.93
Inventory Turnover (TTM) -- 1.88 3.36
Asset Turnover (TTM) 0.00 0.32 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -128.02 6.40 11.17
Return on Assets - 5 Yr. Avg. -46.89 5.50 12.34
Return on Investment (TTM) -144.94 8.95 14.48
Return on Investment - 5 Yr. Avg. -72.71 6.82 16.02
Return on Equity (TTM) -182.75 10.09 15.78
Return on Equity - 5 Yr. Avg. -76.69 8.46 17.01
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -23.06 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cellect Biotechnology Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.